Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...

The virus that causes eastern equine encephalitis, or EEE, has evolved to infect mosquitoes. To be able to spread between ...

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...